Catachem
Generated 5/9/2026
Executive Summary
Catachem Inc., founded in 1978 and headquartered in Cheshire, Connecticut, is a U.S.-based manufacturer of high-quality clinical chemistry reagents, calibrators, and controls for automated analyzers. The company serves veterinary diagnostic laboratories and the research-use-only (RUO) segment of human diagnostics. Operating as an ISO13485-certified and FDA-registered medical device manufacturer, Catachem has built a reputation for accuracy, precision, and strong customer service over its four decades of operation. In recent years, Catachem has expanded beyond its core reagent manufacturing to offer contract development and manufacturing (CDMO) services and custom lyophilization. This diversification positions the company to capitalize on the growing demand for outsourced diagnostic reagent production. While Catachem remains privately held and discloses limited financial information, its established market presence, quality certifications, and broadening service offerings suggest a stable, albeit not high-growth, trajectory. The company is well-positioned to serve niche veterinary and RUO markets, with potential for modest expansion through CDMO partnerships.
Upcoming Catalysts (preview)
- TBDExpansion of CDMO client contracts70% success
- Q3 2026New product launch for veterinary chemistry analyzers60% success
- Q4 2026ISO 13485 recertification or upgrade95% success
- · Pipeline Analysis
- · Competitive Landscape
- · Catalyst Calendar (full 12-month)
- · Bull Case
- · Bear Case
- · Counterfactual Scenarios
- · Valuation Notes
- · SEC Filing Highlights
- · Insider Activity
- · Literature Watch
- · Patent Landscape
- · Mechanism Cluster Map
- · Audio Briefing (5 min)